Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nina U. Gelineau"'
Autor:
Nina U. Gelineau, Astrid van Barneveld, Atia Samim, Lieke Van Zogchel, Nathalie Lak, Michelle L. Tas, Yvette Matser, Annelies M. C. Mavinkurve-Groothuis, Martine van Grotel, Jószef Zsiros, Natasha K. A. van Eijkelenburg, Rutger R. G. Knops, Roelof van Ewijk, Karin P. S. Langenberg, Ronald De Krijger, Laura S. Hiemcke-Jiwa, Ruben Van Paemel, Lotte Cornelli, Katleen De Preter, Bram De Wilde, Ellen Van Der Schoot, Godelieve Tytgat
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Background and aimsSolid tumors account for about 30% of all pediatric cancers. The diagnosis is typically based on histological and molecular analysis of a primary tumor biopsy. Liquid biopsies carry several advantages over conventional tissue biops
Externí odkaz:
https://doaj.org/article/1379e9ffb39d4217ac9e2af4db5290ca
Autor:
Lieke M. J. van Zogchel, Nathalie S. M. Lak, Nina U. Gelineau, Irina Sergeeva, Ellen Stelloo, Joost Swennenhuis, Harma Feitsma, Max van Min, Erik Splinter, Margit Bleijs, Marian Groot Koerkamp, Willemijn Breunis, Michael Torsten Meister, Waleed Hassan Kholossy, Frank C. P. Holstege, Jan J. Molenaar, Wendy W. J. de Leng, Janine Stutterheim, C. Ellen van der Schoot, Godelieve A. M. Tytgat
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundLiquid biopsies combine minimally invasive sample collection with sensitive detection of residual disease. Pediatric malignancies harbor tumor-driving copy number alterations or fusion genes, rather than recurrent point mutations. These reg
Externí odkaz:
https://doaj.org/article/7b442cccd01346f9baef8bf01b4fb357
Autor:
Godelieve A.M. Tytgat, Nathalie S. M. Lak, C. Ellen van der Schoot, Nina U. Gelineau, Lily Zappeij-Kannegieter, Janine Stutterheim, Lieke M. J. van Zogchel, Marjolein Lugtigheid, Ahmad Javadi, Danny A. Zwijnenburg, Jan Koster
Publikováno v:
Cancers
Cancers, Vol 13, Iss 150, p 150 (2021)
Volume 13
Issue 1
Cancers, Vol 13, Iss 150, p 150 (2021)
Volume 13
Issue 1
Simple Summary Sensitive detection of minimal residual disease by RT-qPCR in patients with neuroblastoma is shown to be predictive of outcome, but has not yet been introduced into clinical practice. A panel of multiple mRNA markers increases the sens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2239bc6b34b0b58a5dac67950787b2f
http://europepmc.org/articles/PMC7796198
http://europepmc.org/articles/PMC7796198